ZYDUS LIFESCIENCES (ZYDUSLIFE)
companyActive threads
Zydus Lifesciences shares fall 27% as Q2 profit drops
Zydus Lifesciences Q2 Results: Shares fall after profit drops 27%, margins contract - Published OnNov 4, 2026 | 13:00 IST - Last Updated OnNov 4, 2026 | 13:00 IST The North America formulations business reported revenue of ₹33,145 million, up 21% year-on-year and 7% quarter-on-quarter. Growth was driven by sustained volume expansion in the base business, supplemented by the continued scale-up of the US specialty business. Shares of Zydus Lifesciences Ltd.
Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 crore
Zydus Lifesciences reported a net profit of ₹925.5 crore for the September quarter, which declined by 26.6%. The company's revenue from operations increased by 29.2% to ₹7,909.6 crore during the same period. Total expenses rose significantly to ₹6,806.6 crore, impacting profitability.
Intelligence feed· 1 article in 1440m
Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 crore
Story first reported.